These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 30813947)

  • 1. Osteoblasts are "educated" by crosstalk with metastatic breast cancer cells in the bone tumor microenvironment.
    Kolb AD; Shupp AB; Mukhopadhyay D; Marini FC; Bussard KM
    Breast Cancer Res; 2019 Feb; 21(1):31. PubMed ID: 30813947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stromal-Derived Extracellular Vesicles Suppress Proliferation of Bone Metastatic Cancer Cells Mediated by ERK2.
    Shupp AB; Neupane M; Agostini LC; Ning G; Brody JR; Bussard KM
    Mol Cancer Res; 2021 Oct; 19(10):1763-1777. PubMed ID: 34021072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metastatic breast cancer induces an osteoblast inflammatory response.
    Kinder M; Chislock E; Bussard KM; Shuman L; Mastro AM
    Exp Cell Res; 2008 Jan; 314(1):173-83. PubMed ID: 17976581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteoblasts are a major source of inflammatory cytokines in the tumor microenvironment of bone metastatic breast cancer.
    Bussard KM; Venzon DJ; Mastro AM
    J Cell Biochem; 2010 Dec; 111(5):1138-48. PubMed ID: 20683902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metastatic breast cancer cells suppress osteoblast adhesion and differentiation.
    Mercer RR; Miyasaka C; Mastro AM
    Clin Exp Metastasis; 2004; 21(5):427-35. PubMed ID: 15672867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tasquinimod inhibits prostate cancer growth in bone through alterations in the bone microenvironment.
    Magnusson LU; Hagberg Thulin M; Plas P; Olsson A; Damber JE; Welén K
    Prostate; 2016 Mar; 76(4):383-93. PubMed ID: 26660725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modifying the osteoblastic niche with zoledronic acid in vivo-potential implications for breast cancer bone metastasis.
    Haider MT; Holen I; Dear TN; Hunter K; Brown HK
    Bone; 2014 Sep; 66(100):240-50. PubMed ID: 24971713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer bone metastases are attenuated in a Tgif1-deficient bone microenvironment.
    Haider MT; Saito H; Zarrer J; Uzhunnumpuram K; Nagarajan S; Kari V; Horn-Glander M; Werner S; Hesse E; Taipaleenmäki H
    Breast Cancer Res; 2020 Apr; 22(1):34. PubMed ID: 32272947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Location matters: osteoblast and osteoclast distribution is modified by the presence and proximity to breast cancer cells in vivo.
    Brown HK; Ottewell PD; Evans CA; Holen I
    Clin Exp Metastasis; 2012 Dec; 29(8):927-38. PubMed ID: 22562502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional regulation of tenascin-W by TGF-beta signaling in the bone metastatic niche of breast cancer cells.
    Chiovaro F; Martina E; Bottos A; Scherberich A; Hynes NE; Chiquet-Ehrismann R
    Int J Cancer; 2015 Oct; 137(8):1842-54. PubMed ID: 25868708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 'Educated' Osteoblasts Reduce Osteoclastogenesis in a Bone-Tumor Mimetic Microenvironment.
    Kolb AD; Dai J; Keller ET; Bussard KM
    Cancers (Basel); 2021 Jan; 13(2):. PubMed ID: 33445695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selenium modifies the osteoblast inflammatory stress response to bone metastatic breast cancer.
    Chen YC; Sosnoski DM; Gandhi UH; Novinger LJ; Prabhu KS; Mastro AM
    Carcinogenesis; 2009 Nov; 30(11):1941-8. PubMed ID: 19759193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD8
    Monteiro AC; Bonomo A
    Bone; 2021 Sep; 150():116014. PubMed ID: 34022456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metastatic breast cancer cells inhibit osteoblast differentiation through the Runx2/CBFβ-dependent expression of the Wnt antagonist, sclerostin.
    Mendoza-Villanueva D; Zeef L; Shore P
    Breast Cancer Res; 2011 Oct; 13(5):R106. PubMed ID: 22032690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct crosstalk between cancer and osteoblast lineage cells fuels metastatic growth in bone via auto-amplification of IL-6 and RANKL signaling pathways.
    Zheng Y; Chow SO; Boernert K; Basel D; Mikuscheva A; Kim S; Fong-Yee C; Trivedi T; Buttgereit F; Sutherland RL; Dunstan CR; Zhou H; Seibel MJ
    J Bone Miner Res; 2014 Sep; 29(9):1938-49. PubMed ID: 24676805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MMP-13 stimulates osteoclast differentiation and activation in tumour breast bone metastases.
    Pivetta E; Scapolan M; Pecolo M; Wassermann B; Abu-Rumeileh I; Balestreri L; Borsatti E; Tripodo C; Colombatti A; Spessotto P
    Breast Cancer Res; 2011 Oct; 13(5):R105. PubMed ID: 22032644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin analogue UBS109 prevents bone loss in breast cancer bone metastasis mouse model: involvement in osteoblastogenesis and osteoclastogenesis.
    Yamaguchi M; Zhu S; Zhang S; Wu D; Moore TM; Snyder JP; Shoji M
    Cell Tissue Res; 2014 Jul; 357(1):245-52. PubMed ID: 24723227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer exosomes contribute to pre-metastatic niche formation and promote bone metastasis of tumor cells.
    Yuan X; Qian N; Ling S; Li Y; Sun W; Li J; Du R; Zhong G; Liu C; Yu G; Cao D; Liu Z; Wang Y; Qi Z; Yao Y; Wang F; Liu J; Hao S; Jin X; Zhao Y; Xue J; Zhao D; Gao X; Liang S; Li Y; Song J; Yu S; Li Y
    Theranostics; 2021; 11(3):1429-1445. PubMed ID: 33391543
    [No Abstract]   [Full Text] [Related]  

  • 19. Wenshen Zhuanggu formula mitigates breast cancer bone metastasis through the signaling crosstalk among the Jagged1/Notch, TGF-β and IL-6 signaling pathways.
    Wu C; Chen M; Sun Z; Ye Y; Han X; Qin Y; Liu S
    J Ethnopharmacol; 2019 Mar; 232():145-154. PubMed ID: 30576770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local estrogen axis in the human bone microenvironment regulates estrogen receptor-positive breast cancer cells.
    Amanatullah DF; Tamaresis JS; Chu P; Bachmann MH; Hoang NM; Collyar D; Mayer AT; West RB; Maloney WJ; Contag CH; King BL
    Breast Cancer Res; 2017 Nov; 19(1):121. PubMed ID: 29141657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.